Frolic Pharmaceuticals Private Limited
About Frolic Pharmaceuticals Private Limited
Data last updated:
Frolic Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the general construction services segment of the infrastructure and utilities sector. It was incorporated on 23 August 1993 and has been in existence for over 33 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1993PTC054940. Its GSTIN is 07AAACF1678C1ZX (Delhi).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹3.07 Lakh. It is led by directors including Umesh Kumar Aggarwal and Vandana Aggarwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mb – 24 – B Indra Prakash Building 21 Barakhamba Road, New Delhi, Delhi, India – 110001.
As per the financials filed for FY 2025, the company reported a revenue of ₹82,055, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹2,089 (net margin 2.5%) and EBITDA of ₹2,093 (EBITDA margin 2.6%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 2% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Frolic Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressMb – 24 – B Indra Prakash Building 21 Barakhamba Road, New Delhi, Delhi, India – 110001
- IndustryInfrastructure and Utilities, General Construction Services
To see the full contact details of Frolic Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Frolic Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Frolic Pharmaceuticals Private Limited, buy the company report.
Financials of Frolic Pharmaceuticals Private Limited
FY 2025 filings availableFrolic Pharmaceuticals Private Limited reported revenue of ₹82,055 (up 14% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 2% over five years, including 14% growth in the latest year. EBITDA fell 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2,093 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2,089 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.6% | ||||
| Net Profit Margin | 2.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Frolic Pharmaceuticals Private Limited, buy the company report.
Board of directors of Frolic Pharmaceuticals Private Limited
Frolic Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Umesh Kumar Aggarwal Also directs: Csa Pharma Tech (Pvt) Ltd, Ambalika Holdings Private Limited | Director | 15 Nov 1996 | 29 Years 11 Months | Current |
| Vandana Aggarwal Also directs: Csa Pharma Tech (Pvt) Ltd, Ambalika Holdings Private Limited | Director | 15 Dec 1999 | 26 Years 10 Months | Current |
| Yashsvi Aggarwal | Director | 30 Jun 2000 | 26 Years 3 Months | Current |
Auditor
Frolic Pharmaceuticals Private Limited is audited by ANIL REENU & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ANIL REENU & CO | FY 2020 | 014096N |
Shareholding
The shareholding of Frolic Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Frolic Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Frolic Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Frolic Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Frolic Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACF1678C1ZX | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Frolic Pharmaceuticals Private Limited, buy the company report.
Recent activity
Frolic Pharmaceuticals Private Limited has 3 board changes on record since 1996: 3 appointments. The latest: Yashsvi Aggarwal was appointed as Director on 30 Jun 2000.
Frequently asked questions
Frolic Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in general construction services, within the infrastructure and utilities industry. It was incorporated on 23 August 1993 (33+ years old) and is registered under CIN U74899DL1993PTC054940.
Frolic Pharmaceuticals has 3 current directors:
- Umesh Kumar Aggarwal - Director
- Vandana Aggarwal - Director
- Yashsvi Aggarwal - Director
The latest financial statements of Frolic Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Frolic Pharmaceuticals is 07AAACF1678C1ZX, registered in Delhi.
The CIN (Corporate Identification Number) of Frolic Pharmaceuticals is U74899DL1993PTC054940. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Frolic Pharmaceuticals was incorporated on 23 August 1993, making it 33+ years old. It is registered with the Registrar of Companies, Delhi.
Yashsvi Aggarwal was appointed as Director on 30 Jun 2000. Vandana Aggarwal was appointed as Director on 15 Dec 1999. Umesh Kumar Aggarwal was appointed as Director on 15 Nov 1996.
The registered office of Frolic Pharmaceuticals is at Mb – 24 – B Indra Prakash Building 21 Barakhamba Road, New Delhi, Delhi, India – 110001.
Frolic Pharmaceuticals operates in the infrastructure and utilities industry, in the general construction services segment.
The compliance status of Frolic Pharmaceuticals is compliant as of 18 July 2026. The company is actively filing with the Registrar of Companies.